X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CEREBELLUM

期刊標題檢索 CEREBELLUM 最新評論: Hello, do you have any results? (2023-08-25)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CEREBELLUM]您好,您是該頁面的第 16362 位訪客。

期刊簡介
期刊名稱CEREBELLUM CEREBELLUM
LetPub Score
6.2
50 ratings
Rate

Reputation
7.5

Influence
5.1

Speed
7.0

期刊簡稱CEREBELLUM
ISSN1473-4222
E-ISSN1473-4230
h-index61
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.401.2581.187
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Neurology (clinical)
Q192 / 400
Category: Medicine
Subcategory: Neurology
Q250 / 192

自引率 (2023-2024)11.10%自引率趨勢
掲載範囲
Official publication of the Society for Research on the Cerebellum devoted to genetics of cerebellar ataxias, role of cerebellum in motor control and cognitive function, and amid an ageing population, diseases associated with cerebellar dysfunction.

The Cerebellum is a central source for the latest developments in fundamental neurosciences including molecular and cellular biology; behavioural neurosciences and neurochemistry; genetics; fundamental and clinical neurophysiology; neurology and neuropathology; cognition and neuroimaging.

The Cerebellum benefits neuroscientists in molecular and cellular biology; neurophysiologists; researchers in neurotransmission; neurologists; radiologists; paediatricians; neuropsychologists; students of neurology and psychiatry and others.
官方網站https://www.springer.com/12311
在線稿件提交https://www.editorialmanager.com/cere
開放訪問No
出版商Springer US
主題領域医学
出版國/地區UNITED STATES
發行頻率四半期刊行
創刊年2002
每年文章數130每年文章數趨勢
黃金OA百分比33.51%
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ3158/310
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-4222%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【CEREBELLUM】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS NEUROSCIENCEH-index: 357

    CiteScore: 35.00
    NATURE NEUROSCIENCEH-index: 375

    CiteScore: 38.60
    Molecular NeurodegenerationH-index: 66

    CiteScore: 23.00
    NeuronH-index: 430

    CiteScore: 24.50
    TRENDS IN NEUROSCIENCESH-index: 269

    CiteScore: 26.50
    Annual Review of NeuroscienceH-index: 224

    CiteScore: 25.30
    Journal of NeuroinflammationH-index: 92

    CiteScore: 15.90
    PROGRESS IN NEUROBIOLOGYH-index: 212

    CiteScore: 12.80
    NeurotherapeuticsH-index: 100

    CiteScore: 11.00
    GLIAH-index: 148

    CiteScore: 13.10
    學科內最受檢索的期刊 頁面查看次數
    Journal of Neuroinflammation196993
    NEUROSCIENCE191768
    JOURNAL OF NEUROSCIENCE185808
    BRAIN RESEARCH140181
    MOLECULAR NEUROBIOLOGY129627
    Neuron121669
    NEUROSCIENCE LETTERS115231
    CNS Neuroscience & Therapeutics110063
    NATURE NEUROSCIENCE98388
    CEREBRAL CORTEX98080
  •  

    CEREBELLUM CEREBELLUM
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CEREBELLUM] 的評論撰寫評論
作者: 归元冰桃


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-25 18:15:16 評論於
Hello, do you have any results?
(0) 讚! | 归元冰桃

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:56:48 評論於
We suggest dividing the discussion of research limitations into three parts: (1) presenting research limitations; (2) explaining research limitations in detail; and (3) proposing future research directions or improvement measures. Discussing research limitations in this order can help you clearly identify research gaps without compromising the quality and validity of the study
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:49:14 評論於
The relationship between the findings of this study and relevant theories; Limitations or shortcomings of your research; Practical significance and application value of this study; Suggestions for future research
(0) 讚! | 维尔娜菲茨杰拉德

作者: 陶宜三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 20:36:09 評論於
What can we generally discuss in a discussion?
(0) 讚! | 陶宜三岁啦

作者: 平原文波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 19:37:24 評論於
How to write about limitations in a discussion?
(0) 讚! | 平原文波

作者: 平原依珊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-10-05 18:58:02 評論於
Review Speed: 2.0 | Submission Acceptance Rate: 75.0 Experience Sharing: Previously rejected once and asked us to resubmit... Submitted on May 7th, received feedback on July 6th... Given three months for revisions. Accepted on October 5th
(0) 讚! | 平原依珊

作者: 平原依珊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-05-10 14:31:58 評論於
Review Speed: 1.0 Experience Sharing: The first submission was rejected, with a review duration of 15 days. There were two reviewers, one thought minor revisions were sufficient for acceptance, while the other raised a few questions. In the end, the editor rejected our submission, but encouraged us to resubmit after revisions. We resubmitted on May 7th, and on May 9th, it entered the "under review" status. Feeling quite nervous, I hope for a positive outcome
(0) 讚! | 平原依珊

作者: 彬丽小可爱


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2016-03-14 13:32:53 評論於
First time投, hoping for a good outcome
(0) 讚! | 彬丽小可爱

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CEREBELLUM] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*